Email: cspc@cspc.cn

Contact Us
EN

News

News

Home > Media > News > VOLUNTARY ANNOUNCEMENT APREPITANT INJECTION OBTAINS DRUG REGISTRATION APPROVAL

VOLUNTARY ANNOUNCEMENT APREPITANT INJECTION OBTAINS DRUG REGISTRATION APPROVAL

September 10, 2024

VOLUNTARY ANNOUNCEMENT APREPITANT INJECTION OBTAINS DRUG REGISTRATION APPROVAL

VOLUNTARY ANNOUNCEMENT APREPITANT INJECTION OBTAINS DRUG REGISTRATION APPROVAL

Previous: VOLUNTARY ANNOUNCEMENT AMPHOTERICIN B LIPOSOME FOR INJECTION OBTAINS DRUG REGISTRATION APPROVAL

Next: VOLUNTARY ANNOUNCEMENT DEXRAZOXANE FOR INJECTION OBTAINS DRUG REGISTRATION APPROVAL

Contact Us

Phone:

+86 311 8703 7015

Email:

cspc@cspc.cn

Products

Science

About Us

Legal terms Privacy protection
Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |

Wechat